Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
Streamlined Integrated Project Delivery Tackles Design Challenges
Encompass Health Rehabilitation Hospital of Central Florida - Sumter County Opens
Rudolph and Sletten Awarded $960M for New UCSF Benioff Children's Hospital
How Designers Create Welcoming Senior Care Communities
Data-Driven Decisions: How Analytics Are Shaping Healthcare Facility Planning